Enabling Technologies for Immunotherapy Development

Conference

AIChE Annual Meeting

Year

2018

Proceeding

2018 AIChE Annual Meeting

Group

Topical Conference: Immunotherapy

Type

Oral

Room

Pennsylvania East

Location

Westin Convention Center

Time

Wednesday, October 31, 2018 - 8:00am to 10:30am

Chair(s)

Mukherjee, A., University of California Santa Barbara

This session will focus on technologies that support the development of novel immunotherapies. Topics of interest include but are not limited to genome editing in primary immune cells, in vivo imaging, and high-throughput protein engineering for immunotherapy applications.

Presentations

8:00 AM

(454a) Eradication of Primary and Cancer Stem Cells By Chemically Self-Assembled Nanoring Targeted T-Cells

8:18 AM

(454b) Inhibition of Peanut Induced Mast Cell Degranulation By Designing Covalent Heterobivalent Inhibitors

8:36 AM

(454c) Remote Control of Engineered T Cells Using Photothermal Pulses

8:54 AM

(454d) Serum Antibody Profiling of Nivolumab/Azacytidine-Treated Acute Myeloid Leukemia Patients Via High-Throughput Sequencing of Peptide Phage-Display Library

9:12 AM

Break

9:19 AM

(454e) Yeast Surface Display Techniques Enhance Development of Chimeric Antigen Receptors for Hematologic Malignancies

9:37 AM

(454f) Efficient Incorporation of Matrix Protein M2 into Influenza Virus-like Particles (VLPs) for Improved Vaccine Manufacturing and Efficacy

9:55 AM

(454g) Cytokine-like Regulation of T-Cell Fate Mediated By Tryptophan-Derived Microbiota Metabolites

Arul Jayaraman

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Do you already own this?

Pricing

Individuals

AIChE Pro Members	$150.00
AIChE Graduate Student Members	Free
AIChE Undergraduate Student Members	Free
AIChE Explorer Members	$225.00
Non-Members	$225.00